论文部分内容阅读
目的:分析氨溴索联合干扰素以雾化吸入方式为慢性支气管炎病人进行治疗的实际效用。方法:任意抽选本院接收的64例慢性支气管炎病症急性发作的病人,32例病人纳入对照组,其他病人则归纳为人数相等的观察组。对照组病人单独接受氨溴索药物治疗,通过雾化吸入方式运用氨溴索以及干扰素为观察组病人实施治疗。结果:根据统计的资料可知,观察组的病人病情复原状况明显比对照组更好P<0.05。结论:当患有慢性支气管炎的病人病情突然发作时,运用干扰素以及氨溴索以雾化吸入形式给病人用药能够迅速控制病情,提升治疗的有效性,值得广泛普及。
OBJECTIVE: To analyze the practical utility of ambroxol combined with interferon in the treatment of patients with chronic bronchitis by aerosol inhalation. METHODS: Sixty-four patients with acute exacerbation of chronic bronchitis were enrolled in this study. Thirty-two patients were enrolled in the control group. Other patients were grouped into observation groups of equal numbers. Patients in the control group received ambroxol alone and were treated with inhalation of ambroxol and interferon for the observation group. Results: According to the statistical data, the patients in the observation group showed significantly better disease recovery status than the control group (P <0.05). CONCLUSIONS: When patients with chronic bronchitis have a sudden onset of illness, the use of interferon and ambroxol in the form of inhaled aerosol can rapidly control the condition and improve the effectiveness of the treatment, which is worth popularizing.